Nomelcitinib
4-[(5-chloro-3-methylsulfonyl-2-pyridinyl)amino]-6-(cyclopropanecarbonylamino)-N-(trideuteriomethyl)pyridazine-3-carboxamide
Molecular Identity
Nomelcitinib
4-[(5-chloro-3-methylsulfonyl-2-pyridinyl)amino]-6-(cyclopropanecarbonylamino)-N-(trideuteriomethyl)pyridazine-3-carboxamide
PubChem CID: 170678247
2D Structure
Properties
C16H17ClN6O4S
Molecular Formula
427.90
Molecular Weight
g/mol
427.0909
Exact Mass
Da
0.6
XLogP
Drug-like (Lipinski: < 5)
151
TPSA
May have limited oral absorption
3
H-Bond Donors
8
H-Bond Acceptors
698
Complexity
SMILES
Canonical SMILES
SMILES: Synonyms(9)
Nomelcitinibnomelcitinib [INN]4N852Y7MHEGTPL14360compound 52 [WO2022135430]D-25702794195-73-43-Pyridazinecarboxamide, 4-[[5-chloro-3-(methylsulfonyl)-2-pyridinyl]amino]-6-[(cyclopropylcarbonyl)amino]-N-(methyl-d3)-4-[(5-chloro-3-methylsulfonyl-2-pyridinyl)amino]-6-(cyclopropanecarbonylamino)-N-(trideuteriomethyl)pyridazine-3-carboxamide
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Nomelcitinib
Loading drug network...